1-3 of 3
Bruno Costa
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Characterization of Relapse and Second-Line Therapy in Lenalidomide-Refractory, Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma: A Subanalysis of the Phase 3 First Trial

Salmon Manier, Meletios A. Dimopoulos, MD, Cyrille Hulin, MD, Xavier Leleu, MD PhD, Michel Delforge, Katja C. Weisel, MD, Ruiyun Jiang, Shankar Srinivasan, PhD MBA, Bruno Costa, Suzanne Robinson, Thierry Facon, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3122.
https://doi.org/10.1182/blood-2019-124557
Published: 2019
Journal Articles

Carfilzomib, Pomalidomide and Dexamethasone (KPd) in Patients with Multiple Myeloma Refractory to Bortezomib and Lenalidomide. the EMN011 Trial

Pieter Sonneveld, MDPhD, Sonja Zweegman, MDPhD, Michele Cavo, MD, Kazem Nasserinejad, PhD, Rosella Troia, Ludek Pour, MD, Sandra Croockewit, MD, Paolo Corradini, MD, Francesca Patriarca, MD, Kalung Wu, MD, Jolanda Droogendijk, MD, Annemiek Broyl, MD PhD, Monique C Minnema, MD PhD, Bruno Costa, Karim Saad Iskander, MD, Mario Boccadoro, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 801.
https://doi.org/10.1182/blood-2018-99-114029
Published: 2018
Journal Articles

Characterization of Circulating and Bone Marrow Derived Exosomes in Multiple Myeloma Patients

Bruna Velosa Ferreira, MD, Paulo Lucio, MD PhD, Manuel Neves, MD, Antonio Parreira, MD PhD, Bruno Costa-Silva, PhD, Cristina Joao, MD PhD MSc
Journal: Blood
Blood (2018) 132 (Supplement 1): 3172.
https://doi.org/10.1182/blood-2018-99-117656
Published: 2018